Outcomes of pregnancies from the tildrakizumab phase I-III clinical development programme
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:183 |
|---|---|
| Enthalten in: |
The British journal of dermatology - 183(2020), 1 vom: 15. Juli, Seite 184-186 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Haycraft, K [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Monoclonal, Humanized |
|---|
| Anmerkungen: |
Date Completed 14.05.2021 Date Revised 31.05.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/bjd.18897 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM305915282 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM305915282 | ||
| 003 | DE-627 | ||
| 005 | 20231225122217.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bjd.18897 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1019.xml |
| 035 | |a (DE-627)NLM305915282 | ||
| 035 | |a (NLM)31995637 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Haycraft, K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Outcomes of pregnancies from the tildrakizumab phase I-III clinical development programme |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.05.2021 | ||
| 500 | |a Date Revised 31.05.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Antibodies, Monoclonal, Humanized |2 NLM | |
| 650 | 7 | |a tildrakizumab |2 NLM | |
| 650 | 7 | |a DEW6X41BEK |2 NLM | |
| 700 | 1 | |a DiRuggiero, D |e verfasserin |4 aut | |
| 700 | 1 | |a Rozzo, S J |e verfasserin |4 aut | |
| 700 | 1 | |a Mendelsohn, A M |e verfasserin |4 aut | |
| 700 | 1 | |a Bhutani, T |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The British journal of dermatology |d 1951 |g 183(2020), 1 vom: 15. Juli, Seite 184-186 |w (DE-627)NLM000000361 |x 1365-2133 |7 nnns |
| 773 | 1 | 8 | |g volume:183 |g year:2020 |g number:1 |g day:15 |g month:07 |g pages:184-186 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/bjd.18897 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 183 |j 2020 |e 1 |b 15 |c 07 |h 184-186 | ||